Add to ORKGPlasma cell leukemia (PCL) is a rare lymphoproliferative disorder characterized by a malignant proliferation of plasma cells in blood and bone marrow, Treatment of primary PCL has been mostly disappointing, Three patients with primary PCL are described who received high-dose melphalan with autologous PBSC support after vincristine, doxorubicine and dexamethasone (VAD), high-dose cyclophosphamide, and etoposide, cisplatinum, dexamethasone and cytosine arabinoside (EDAP) courses, All patients were in CR posttransplantation, One patient relapsed after 3 months; the other patients are still in CR, after 14 and 26 months, respectively, These results in conjunction with data from the literature suggest that intensive chemotherapy for PCL is promi...
Plasma cell leukemia (PCL) is a rare and aggressive plasma cell disorder, characterized by the prese...
Plasma cell leukemia (PCL) is a rare form of malignant plasma cell dyscrasia. It can occur as a prim...
Plasma cell leukemia (PCL) is a rare and aggressive variant of plasma cell dyscrasias that can occur...
Plasma cell leukemia (PCL) is a rare lymphoproliferative disorder characterized by a malignant proli...
Primary plasma cell leukaemia (PPCL) is a rare form of plasma cell dyscrasia. Conventional melphalan...
Primary plasma cell leukemia (PPCL) is an aggressive and rare variant of multiple myeloma (MM), char...
Primary plasma cell leukemia (PPCL) is an aggressive and rare variant of multiple myeloma (MM), char...
Background Primary plasma cell leukemia is a rare disorder accounting for less than 5% of malignant ...
AbstractPrimary plasma cell leukemia (pPCL) is an uncommon but aggressive plasma cell malignancy ass...
Primary plasma cell leukemia (pPCL) is a rare and aggressive variant of multiple myeloma (MM) with p...
Background: Plasma cell leukemia (PCL) is a rare lymphoproliferative disorder considered to be a var...
Abstract: Several trials have suggested that intensive post-remission therapy may prolong the durati...
International audiencePURPOSE: Primary plasma cell leukemia (pPCL) is a rare and aggressive malignan...
Primary plasma cell leukaemia (PCL) is a rare, aggressive neoplasm of plasma cell dyscrasia. Convent...
International audiencePurposePrimary plasma cell leukemia (pPCL) is a rare and aggressive malignancy...
Plasma cell leukemia (PCL) is a rare and aggressive plasma cell disorder, characterized by the prese...
Plasma cell leukemia (PCL) is a rare form of malignant plasma cell dyscrasia. It can occur as a prim...
Plasma cell leukemia (PCL) is a rare and aggressive variant of plasma cell dyscrasias that can occur...
Plasma cell leukemia (PCL) is a rare lymphoproliferative disorder characterized by a malignant proli...
Primary plasma cell leukaemia (PPCL) is a rare form of plasma cell dyscrasia. Conventional melphalan...
Primary plasma cell leukemia (PPCL) is an aggressive and rare variant of multiple myeloma (MM), char...
Primary plasma cell leukemia (PPCL) is an aggressive and rare variant of multiple myeloma (MM), char...
Background Primary plasma cell leukemia is a rare disorder accounting for less than 5% of malignant ...
AbstractPrimary plasma cell leukemia (pPCL) is an uncommon but aggressive plasma cell malignancy ass...
Primary plasma cell leukemia (pPCL) is a rare and aggressive variant of multiple myeloma (MM) with p...
Background: Plasma cell leukemia (PCL) is a rare lymphoproliferative disorder considered to be a var...
Abstract: Several trials have suggested that intensive post-remission therapy may prolong the durati...
International audiencePURPOSE: Primary plasma cell leukemia (pPCL) is a rare and aggressive malignan...
Primary plasma cell leukaemia (PCL) is a rare, aggressive neoplasm of plasma cell dyscrasia. Convent...
International audiencePurposePrimary plasma cell leukemia (pPCL) is a rare and aggressive malignancy...
Plasma cell leukemia (PCL) is a rare and aggressive plasma cell disorder, characterized by the prese...
Plasma cell leukemia (PCL) is a rare form of malignant plasma cell dyscrasia. It can occur as a prim...
Plasma cell leukemia (PCL) is a rare and aggressive variant of plasma cell dyscrasias that can occur...